Nanoscale distribution of CD20 on B-cell lymphoma tumour cells and its potential role in the clinical efficacy of rituximab
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoscale distribution of CD20 on B-cell lymphoma tumour cells and its potential role in the clinical efficacy of rituximab
Authors
Keywords
-
Journal
JOURNAL OF MICROSCOPY
Volume 254, Issue 1, Pages 19-30
Publisher
Wiley
Online
2014-02-06
DOI
10.1111/jmi.12112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoscale mapping and organization analysis of target proteins on cancer cells from B-cell lymphoma patients
- (2013) Mi Li et al. EXPERIMENTAL CELL RESEARCH
- Atomic force microscopy study of the antigen-antibody binding force on patient cancer cells based on ROR1 fluorescence recognition
- (2013) Mi Li et al. JOURNAL OF MOLECULAR RECOGNITION
- Tumour heterogeneity
- (2013) Barbara Marte NATURE
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Atomic force microscopy imaging of live mammalian cells
- (2013) Mi Li et al. Science China-Life Sciences
- B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
- (2013) Maria J Leandro ARTHRITIS RESEARCH & THERAPY
- Nanoscale Imaging of the Candida–Macrophage Interaction Using Correlated Fluorescence-Atomic Force Microscopy
- (2012) Sofiane El-Kirat-Chatel et al. ACS Nano
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers
- (2012) Suping Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Combined Atomic Force Microscopy–Fluorescence Microscopy: Analyzing Exocytosis in Alveolar Type II Cells
- (2012) Elena Hecht et al. ANALYTICAL CHEMISTRY
- Atomic force microscopy-based force spectroscopy - biological and biomedical applications
- (2012) Filomena A. Carvalho et al. IUBMB LIFE
- Non-Hodgkin lymphoma
- (2012) Kate R Shankland et al. LANCET
- Targeting malignant B cells with an immunotoxin against ROR1
- (2012) Sivasubramanian Baskar et al. mAbs
- Single-cell analysis of population context advances RNAi screening at multiple levels
- (2012) Berend Snijder et al. Molecular Systems Biology
- High-speed atomic force microscopy coming of age
- (2012) Toshio Ando NANOTECHNOLOGY
- Force probing of individual molecules inside the living cell is now a reality
- (2012) Lene B Oddershede Nature Chemical Biology
- Anti-CD20 Antibody Therapy for B-Cell Lymphomas
- (2012) David G. Maloney NEW ENGLAND JOURNAL OF MEDICINE
- Using Cell-to-Cell Variability--A New Era in Molecular Biology
- (2012) L. Pelkmans SCIENCE
- ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy
- (2012) Guilly Rebagay et al. Frontiers in Oncology
- Rituximab resistance
- (2011) Andrew R. Rezvani et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- The future of anti-CD20 monoclonal antibodies: are we making progress?
- (2011) W. Alduaij et al. BLOOD
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Interdependency of cell adhesion, force generation and extracellular proteolysis in matrix remodeling
- (2011) R. Kirmse et al. JOURNAL OF CELL SCIENCE
- Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
- (2011) Laurie H. Sehn et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL)
- (2011) Sabrina Uhrmacher et al. LEUKEMIA RESEARCH
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
- (2011) Ryan D. Morin et al. NATURE
- Five challenges to bringing single-molecule force spectroscopy into living cells
- (2011) Yves F Dufrêne et al. NATURE METHODS
- Cellular Heterogeneity: Do Differences Make a Difference?
- (2010) Steven J. Altschuler et al. CELL
- ROR1 expression is not a unique marker of CLL
- (2010) Gábor Barna et al. HEMATOLOGICAL ONCOLOGY
- The Path to Personalized Medicine
- (2010) Margaret A. Hamburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab: Mechanism of Action
- (2010) George J. Weiner SEMINARS IN HEMATOLOGY
- CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies
- (2010) Stephen A. Beers et al. SEMINARS IN HEMATOLOGY
- Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma
- (2009) B. Li et al. BLOOD
- Force probing surfaces of living cells to molecular resolution
- (2009) Daniel J Müller et al. Nature Chemical Biology
- Paper-supported 3D cell culture for tissue-based bioassays
- (2009) R. Derda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Decade of Rituximab: Improving Survival Outcomes in Non-Hodgkin's Lymphoma
- (2008) Arturo Molina Annual Review of Medicine
- Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver
- (2008) Atsushi Suzuki et al. HEPATOLOGY
- Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma
- (2008) Bruce D. Cheson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monoclonal antibodies in the treatment of lymphoid malignancies
- (2007) Panagiotis Tsirigotis et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More